In today’s era, women’s health is no longer seen as a set of isolated concerns; it is understood as a continuous journey shaped by hormonal changes, emotional wellbeing, and reproductive milestones.
From puberty, through early adulthood, motherhood, and midlife changes, the need for safe, natural, evidence-supported solutions has become a key focus within the industry. As this shift continues, traditional botanicals backed by modern scientific research are emerging as important holistic alternatives in supporting women’s overall wellbeing.
Among these, shatavari (Asparagus racemosus) holds a distinctive place. It has been a revered botanical in Ayurveda for centuries and is associated with female vitality, reproductive balance, and resilience. It has long been linked with women’s health across different life stages. Today, advances in botanical science are enabling this traditional herb to be standardized, clinically evaluated, and positioned for contemporary wellness applications.
SRI-81 Shatavari represents one such evolution – a root-only, full-spectrum extract developed through years of focused botanical research. Rather than isolating single compounds, it preserves the natural phytochemical complexity of the root while standardizing total shatavarins to a scientifically validated range that supports consistency and efficacy.
This balance allows the ingredient to retain its traditional adaptogenic profile while meeting modern expectations of quality, reproducibility, and traceability. The extract is produced without the use of harsh solvents and is designed to maintain the integrity of the plant’s bioactive matrix.
Equally important is the control over sourcing and manufacturing. A vertically integrated supply chain, spanning certified organic cultivation, extraction facilities, analytical laboratories, and global distribution, ensures authenticity and consistency from soil to finished ingredient.
Such integration is particularly relevant in the botanical category, where variability, adulteration, and supply instability remain ongoing challenges. By maintaining oversight across the entire value chain, SRI-81 aims to provide manufacturers with reliability alongside efficacy.
Expanding clinical portfolio
What distinguishes SRI-81 Shatavari in the global shatavari category is its expanding clinical portfolio. It is currently the most clinically researched Shatavari extract, supported by 18 human clinical studies: 5 published, 4 completed, and 9 ongoing.
This level of structured investigation positions SRI-81 as a data-driven botanical solution for women’s health innovation. Its five published studies include the following:
A randomized, double-blind, placebo-controlled study in postpartum women demonstrated that shatavari root extract significantly reduced the time to noticeable breast fullness and increased expressed milk volume within 72 hours. Improvements in maternal well-being and satisfaction were also reported, reinforcing its traditional association with lactation support.1
In adult women, a randomized, double-blind, placebo-controlled clinical study evaluating female sexual wellness reported significant improvements across Female Sexual Function Index domains, including desire, arousal, lubrication, and satisfaction. The study also observed reductions in sexual distress scores and improvements in mood-state parameters, alongside favorable shifts in reproductive hormone markers.2
In women experiencing menopausal symptoms, supplementation with shatavari root extract over eight weeks resulted in significant reductions in total Menopause Rating Scale (MRS) scores. Improvements were seen across somato-vegetative, psychological and urogenital domains, with additional reductions in hot flash frequency and perceived stress.3
A separate randomized, double-blind, placebo-controlled trial in perimenopausal women demonstrated significant improvements in menopausal symptom scores, reductions in perceived stress, and positive changes in quality-of-life assessments. Notably, serum estradiol levels showed supportive trends, reflecting potential endocrine-modulating effects during transitional hormonal phases.4
In women with polycystic ovarian syndrome (PCOS), a 12-week randomized, double-blind, placebo-controlled trial reported reductions in follicle count and improvements in ovarian morphology, alongside decreases in perceived stress scores. Hormonal parameters, including FSH, LH, and testosterone, showed normalization trends, supporting shatavari’s role in complex hormonal environments.5
Convergence of tradition and modern science
Collectively, these five published studies span critical stages of women’s health – from postpartum recovery and sexual wellbeing to perimenopause, menopause, and PCOS – demonstrating broad life-stage applicability.
This growing evidence base reflects the changing expectations of consumers and healthcare professionals alike. Women are increasingly seeking solutions that address not only specific symptoms but overall wellbeing, including hormonal harmony, emotional resilience, sleep quality, vitality, and long-term healthy aging. Botanicals that can support multiple interconnected aspects of health are therefore gaining traction, particularly when supported by clinical validation and transparent manufacturing practices.
As the women’s health category continues to expand globally, the convergence of traditional botanical wisdom with modern scientific validation is likely to shape future innovation. Ingredients that combine heritage, clinical credibility, traceable sourcing, and sustainable production are positioned to meet evolving expectations within the nutraceutical space.
References
- Ajgaonkar, A.; et al. Shatavari (Asparagus racemosus Willd) root extract for postpartum lactation: A randomised, double-blind, placebo-controlled study. Journal of Obstetrics and Gynaecology. 2025; 45:1, 2564168
- Ademola J.; et al. Effects of Shatavari (Asparagus racemosus) Root Extract on Sexual Wellness in Women: Findings from a Prospective, Randomized, Double-Blind, Three-Arm, Parallel-Group, Placebo-Controlled Study. Int J Womens Health. 2026;18:561213
- Ademola, J.; et al. Efficacy and safety of Shatavari root extract (Asparagus racemosus) for menopausal symptoms: a randomized, double-blind, three-arm, placebo-controlled study. Frontiers in reproductive health. 2025; 7, 1654503.
- Mahajan, S.; et al. Efficacy and Safety of Shatavari (Asparagus racemosus) Root Extract for Perimenopause: Randomized, Double-Blind, Placebo-Controlled Study. International Journal of Women’s Health. 2025; 17, 4057-4073.
- Mhatre, Y.; et al. Efficacy and safety of Shatavari root extract in women with polycystic ovarian syndrome: A randomized, double-blind, placebo-controlled trial. Frontiers in Endocrinology. 2026.
